An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bristol Myers Squibb (NYSE: BMY) has declared a quarterly dividend of $0.54 per share on its common stock, payable on May 2, 2022, to stockholders of record by April 1, 2022. Additionally, a quarterly dividend of $0.50 per share on its convertible preferred stock will be paid on June 1, 2022, with a record date of May 10, 2022. This consistent dividend policy reflects confidence in the company’s ongoing financial health and commitment to returning value to shareholders.
Positive
Quarterly dividend of $0.54 per share on common stock enhances shareholder income.
Consistent dividend payments indicate financial stability and company confidence.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of fifty-four cents ($0.54) per share on the $.10 par value common stock of the company. The dividend is payable on May 2, 2022 to stockholders of record at the close of business on April 1, 2022.
In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable June 1, 2022, to stockholders of record at the close of business on May 10, 2022.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.